Read twice and referred to the Committee on Foreign Relations.

Original title: “S 5565: Abortion is Health Care Everywhere Act of 2026”

Health centers with a current period of performance of January 1, 2023, through December 31, 2026; February 1, 2023, through January 31, 2027; or March 1, 2023, through February 28, 2027, are required to apply to continue serving their service area through a fiscal year 2027 Service Area Competition in response to a Notice of Funding Opportunity once issued. To avoid a gap in services in service areas served by these health centers, health centers with a current period of performance of January

Original title: “Health Center Program Performance Period Extensions”

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Original title: “S 5564: STOP Neglected Diseases of Poverty Act”

A U.S. Food and Drug Administration investigation resulted in a federal court order, dated Sept. 21, 2026, stopping a warehouse operator from distributing FDA-regulated products including food, drugs, medical devices, and cosmetics until it fixes its operations to meet federal legal requirements.

Original title: “Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions ”

Frustrated by a slump that’s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier clinical trials, intellectual property protections and “fiscal flexibility.”

Original title: “9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe”

Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.

Original title: “S 5460: Healthy Meals Help Kids Learn Act of 2026”

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Sanjay Kumar for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Kumar was convicted of a felony under Federal law for conspiracy to traffic in counterfeit goods. The factual basis supporting Mr. Kumar's conviction, as described below, is conduct relating to the importatio

Original title: “Sanjay Kumar: Final Debarment Order”

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.

Original title: “Government-Owned Inventions; Availability for Licensing”

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.

Original title: “Submission for OMB review; 30-Day Comment Request; the Impact and Costs of Promoting Objectivity in Research 42 CFR Part 50 Subpart F and Responsible Prospective Contractors 45 CFR Part 94 (Office of the Director)”

The FDA today issued a direct final rule that updates its regulations to clarify that non-animal methods can be used where appropriate for testing the safety of drugs and biological products intended for human use before they’re tried in humans.

Original title: “ FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing ”

Newly permanent CBER and CDER directors Karim Mikhail and Michael Davis are widely expected to continue the FDA’s efforts toward an adaptive framework for rare disease therapies. If approved by the Senate, will commissioner nominee Heidi Overton stay the course?

Original title: “Mikhail, Davis on board with regulatory framework tailored to rare disease therapies”

HRSA is awarding supplemental funding under the Rural Quality Improvement Technical Assistance Program to one award recipient in fiscal year 2026 to advance efforts to improve health care and quality of care in rural areas by supporting quality measure implementation, data reporting, and the use of data to drive improvements in quality of care.

Original title: “Notice of Supplemental Funding, Rural Quality Improvement Technical Assistance Program”

The Food and Drug Administration (FDA or Agency) is announcing year five of the Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP). This program facilitates the expedited CMC development of products under an investigational new drug application (IND) based on the anticipated clinical benefit of earlier patient access to the products. FDA has implemented this pilot program to assist with CMC readiness for products regulated by both the Center for Biologics Evaluat

Original title: “Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program; Program Announcement”

HRSA is awarding supplemental funding under the Medicare Rural Hospital Flexibility (Flex) Program Evaluation Cooperative Agreement to one award recipient in fiscal year 2026 to expand analysis, evaluation, and dissemination activities that support Critical Access Hospitals (CAHs) and State Flex Programs.

Original title: “Notice of Supplemental Funding, Medicare Rural Hospital Flexibility Program Evaluation Cooperative Agreement”

Consistent with the Department of Health and Human Services' emphasis on evaluating environmental factors that may affect human health, particularly among children and other potentially vulnerable populations, HHS seeks information on electromagnetic field (EMF) emissions and exposure, particularly RF and wireless, and human health. RF radiation and other forms of non-ionizing electromagnetic (EMF) exposure, will hereafter be referred to as "RF/EMF." Responses will help identify and assess the c

Original title: “Request for Information on Electromagnetic Fields (EMFs), Radiofrequency (RF) Radiation, and Wireless Radiation Exposure”

HRSA is awarding supplemental funding under the State Offices of Rural Health (SORH) Coordination and Development Program to one award recipient in fiscal year 2026 to support expanded technical assistance, capacity-building, and coordination activities for SORH and rural stakeholders nationwide.

Original title: “Notice of Supplemental Funding, State Offices of Rural Health Coordination and Development Program”

The Centers for Disease Control and Prevention (CDC) seeks broad public input on how data intermediaries can be used to support secure, scalable, standards-based public health data exchange. CDC invites public comment to inform the evaluation and to explore how data intermediaries can advance broader goals to prevent disease, detect emerging threats, drive state-of-the-art solutions that empower communities, and strengthen public health systems for a safer, healthier nation.

Original title: “Data Intermediaries and Approaches To Strengthen Public Health Data Exchange”

The Office of the Assistant Secretary for Health (OASH) is extending the solicitation period for nominations for appointment to the National Vaccine Advisory Committee (NVAC) that appeared in the Federal Register of August 12, 2026. All nominations received will be provided to the Assistant Secretary for Health for consideration and appointment. We are taking this action in response to a request for an extension to allow interested persons additional time to provide nominations.

Original title: “Solicitation of Nominations for Membership on the National Vaccine Advisory Committee”